These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29056485)

  • 21. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.
    Salonen J; Laitinen L; Kaukonen AM; Tuura J; Björkqvist M; Heikkilä T; Vähä-Heikkilä K; Hirvonen J; Lehto VP
    J Control Release; 2005 Nov; 108(2-3):362-74. PubMed ID: 16169628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel delivery systems for improving the clinical use of peptides.
    Kovalainen M; Mönkäre J; Riikonen J; Pesonen U; Vlasova M; Salonen J; Lehto VP; Järvinen K; Herzig KH
    Pharmacol Rev; 2015 Jul; 67(3):541-61. PubMed ID: 26023145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.
    Riikonen J; Correia A; Kovalainen M; Näkki S; Lehtonen M; Leppänen J; Rantanen J; Xu W; Araújo F; Hirvonen J; Järvinen K; Santos HA; Lehto VP
    Biomaterials; 2015 Jun; 52():44-55. PubMed ID: 25818412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Curcumin via Hydrophobic Porous Silicon Carrier: Preparation, Characterization, and Toxicological Evaluation In Vivo.
    Zhang Y; Li W; Liu D; Ge Y; Zhao M; Zhu X; Li W; Wang L; Zheng T; Li J
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31661-31670. PubMed ID: 31430116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹⁸F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography.
    Sarparanta M; Mäkilä E; Heikkilä T; Salonen J; Kukk E; Lehto VP; Santos HA; Hirvonen J; Airaksinen AJ
    Mol Pharm; 2011 Oct; 8(5):1799-806. PubMed ID: 21875120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.
    Korhonen E; Rönkkö S; Hillebrand S; Riikonen J; Xu W; Järvinen K; Lehto VP; Kauppinen A
    Eur J Pharm Biopharm; 2016 Mar; 100():1-8. PubMed ID: 26686646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size.
    Santos HA; Riikonen J; Salonen J; Mäkilä E; Heikkilä T; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J
    Acta Biomater; 2010 Jul; 6(7):2721-31. PubMed ID: 20036766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro dissolution methods for hydrophilic and hydrophobic porous silicon microparticles.
    Mönkäre J; Riikonen J; Rauma E; Salonen J; Lehto VP; Järvinen K
    Pharmaceutics; 2011 Jun; 3(2):315-25. PubMed ID: 24310498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Thunderstruck": Plasma-Polymer-Coated Porous Silicon Microparticles As a Controlled Drug Delivery System.
    McInnes SJ; Michl TD; Delalat B; Al-Bataineh SA; Coad BR; Vasilev K; Griesser HJ; Voelcker NH
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4467-76. PubMed ID: 26836366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
    Jarvis KL; Barnes TJ; Prestidge CA
    Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray-dried nanofibrillar cellulose microparticles for sustained drug release.
    Kolakovic R; Laaksonen T; Peltonen L; Laukkanen A; Hirvonen J
    Int J Pharm; 2012 Jul; 430(1-2):47-55. PubMed ID: 22465549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface modified porous silicon with chitosan coating as a pH-responsive controlled delivery system for lutein.
    Li W; Liu D; Song L; Li H; Dai S; Su Y; Li Q; Li J; Zheng T
    Food Funct; 2022 Jun; 13(11):6129-6138. PubMed ID: 35579219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues.
    Tzur-Balter A; Shatsberg Z; Beckerman M; Segal E; Artzi N
    Nat Commun; 2015 Feb; 6():6208. PubMed ID: 25670235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
    Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles.
    Obaidat RM; Tashtoush BM; Bayan MF; Al Bustami RT; Alnaief M
    AAPS PharmSciTech; 2015 Dec; 16(6):1235-44. PubMed ID: 25761387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.